*BI-1123.28

Study Sponsor: Boehringer Ingelheim

Study Title

STREAM-Strategic Reperfusion (With Tenecteplase and Antithrombotic Treatment) Early After Myocardial Infarction

Medicine or Vaccine (generic name)

tenecteplase

Sponsor Identification Number

1123.28

Trial Registry Identification Number(#'s)

NCT00623623

Medical Condition

Myocardial Infarction

Phase

Phase 3

Link to study details on the BI Clinical Study Register

Link to study details on ClinicalTrials.gov (if available)

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report

Additional information about the data and documents available for this study

Date Added to this Site

November 2015